Complete Automated Tissue Staining with Parhelia™ Bio’s Omni-Stainer™ on the OT-2


OT-2 omni-stainer parade

As the spatial biology sector explodes, there is a developing need for an effective, reliable, reproducible, and accessible tissue staining solution. Parhelia™ Bio is making tissue auto-staining accessible to all with the release of the new Omni-Stainer™ C12 for coverslip staining and S12 for slide-mounted samples, used in conjunction with the Opentrons OT-2 for a complete automated tissue staining system.


Find out how Parhelia and Opentrons can help with tissue staining reproducibility, reagent savings, time savings and the rapid implementation of multistep protocols.


Who Should Watch:

  • Anyone interested in histology and tissue staining
  • Lab scientists interested in spatial biology, cell and tissue biology



Access the Webinar Now

Subject to your consent given above, by clicking on "get the webinar", Opentrons may use your personal information to communicate with you for marketing purposes. All information you provide in this site will be governed by our Privacy Policy.



DB912400-0E30-4A10-BB99-EC1C06686CF6_1_201_aNikolay Samusik, PhD

CEO, Parhelia Biosciences Corporation




Nikolay is the CEO and Founder of Parhelia Biosciences and a Co-founder of Akoya Biosciences. Nikolay holds a PhD from Max Plank University and a post-doc with Garry Nolan at Stanford. He has a number of publications in single-cell and computational biology and is a developer of numerous algorithms for single-cell data analysis, including the CODEX software toolkit, X-shift/VorteX, and HyperFinder. Nikolay spent countless hours at the bench staining samples for multiplex microscopy, realizing the need for an affordable auto-staining option for lab scientists. In 2021 he resigned from a senior scientist position at Genentech to dedicate his full-time efforts to save the hands of scientists around the world as CEO of Parhelia Biosciences. His ultimate joy is seeing how affordable quality tissue staining automation can have a positive impact on research and clinical applications.


Originally Aired 10/11/22